{"id":7741,"date":"2025-09-13T11:58:04","date_gmt":"2025-09-13T11:58:04","guid":{"rendered":"https:\/\/www.thevelvetskincentre.com\/blog\/?p=7741"},"modified":"2026-05-27T11:22:20","modified_gmt":"2026-05-27T11:22:20","slug":"psoriasis-biologic-therapies-il17-vs-il23-inhibitors-lucknow","status":"publish","type":"post","link":"https:\/\/www.thevelvetskincentre.com\/blog\/psoriasis-biologic-therapies-il17-vs-il23-inhibitors-lucknow\/","title":{"rendered":"Targeted Biologic Therapies for Psoriasis: IL-17 vs IL-23 Inhibitors Compared"},"content":{"rendered":"

Targeted Biologic Therapies for Psoriasis: IL-17 vs IL-23 Inhibitors Compared <\/span><\/em><\/h1>\n

Summary:<\/strong> Psoriasis is more than a skin condition\u2014it\u2019s an immune-driven disease that often needs advanced medical care. Recent breakthroughs in targeted biologic therapies, especially IL-17 and IL-23 inhibitors, are transforming how patients manage moderate to severe psoriasis. Unlike older treatments, these biologics focus on precise immune pathways, reducing inflammation and controlling flare-ups with fewer side effects. At The Velvet Skin Centre in Lucknow, Dr. Asma Parveen, one of the best dermatologists in Lucknow, offers personalized biologic treatment plans that bring long-lasting relief, improved skin clearance, and a better quality of life for psoriasis patients.<\/span><\/i><\/p>\n

 <\/p>\n

Psoriasis<\/a> is not just a skin condition\u2014it\u2019s a chronic autoimmune disease that affects millions worldwide, including a growing number of patients in Lucknow. For years, treatments were limited to creams, oral drugs, and phototherapy, which often provided only partial or temporary relief. But the rise of <\/span><\/i>targeted biologic therapies<\/i><\/b> has transformed psoriasis management.<\/span><\/i><\/p>\n

\"dermatologist<\/p>\n

Two classes stand out in this revolution: <\/span><\/i>IL-17 inhibitors<\/i><\/b> and <\/span><\/i>IL-23 inhibitors<\/i><\/b>. These biologics go beyond surface-level treatment, targeting the root immune pathways responsible for psoriasis. But which one is better? This blog compares IL-17 vs IL-23 inhibitors to help patients understand how they work, their benefits, and which may be right for them.<\/span><\/i><\/p>\n

At <\/span><\/i>The Velvet Skin Centre<\/span><\/i><\/a> in Lucknow, under the expertise of <\/span><\/i>Dr. Asma Parveen\u2014one of the <\/i><\/b>best dermatologists in Lucknow<\/i><\/b><\/a>, we use biologics as part of advanced psoriasis treatment plans tailored to individual needs.<\/span><\/i><\/p>\n

Understanding Psoriasis and Immune Pathways<\/i><\/b><\/h2>\n

Psoriasis occurs when the immune system becomes overactive and sends faulty signals to skin cells, causing them to grow rapidly and form thick, scaly plaques.<\/span><\/i><\/p>\n

Two major cytokines\u2014<\/span><\/i>Interleukin-17 (IL-17)<\/i><\/b> and <\/span><\/i>Interleukin-23 (IL-23)<\/i><\/b>\u2014play a key role in this inflammation. Targeting them helps interrupt the cycle of skin cell overgrowth and chronic inflammation.<\/span><\/i><\/p>\n

This understanding gave rise to biologic therapies that specifically block these cytokines, offering patients more reliable and sustained results.<\/span><\/i><\/p>\n

What Are Biologic Therapies?<\/i><\/b><\/h2>\n

Biologics are <\/span><\/i>lab-engineered proteins derived from living cells<\/i><\/b> that precisely target immune pathways involved in diseases like psoriasis. Unlike conventional drugs (such as methotrexate or cyclosporine), which affect the entire immune system, biologics work selectively.<\/span><\/i><\/p>\n

Benefits of biologics include:<\/span><\/i><\/p>\n